Osmetech, Seeing Placements Rise, Severs Distribution Deal with Thermo Fisher Unit

The change in its sales strategy comes as Osmetech sees an uptick in placements of its eSensor XT-8 platform, which rose from 18 to 43 during the first six months of the year. Revenues for the period increased 131 percent year over year.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.